Hi Pivalde,
whats your view on the latest Biogen study :
“ In the Phase 3 study, the drug called lecanemab removed built-up plaque in the brain called beta amyloid. Importantly, this also led to a cognitive benefit for patients with early-stage Alzheimer's disease”.
Molecular iron related mechanisms in AD and drug targets, page-2
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $9.473K | 2.440M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 4789714 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130596078 | 31 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |